Article

Clinical utility of overviews on adverse events of pharmacological interventions

2023-01-17

Abstract excerpt

<title>Abstract</title> <p>Background Overviews (i.e., systematic reviews of systematic reviews, meta-reviews, umbrella reviews) are a relatively new type of evidence synthesis. Among others, one reason to conduct an overview is to investigate adverse events (AEs) associated with a healthcare intervention. Overviews aim to provide easily accessible information for healthcare decision makers including clinicians....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 61da9915-d32a-56cb-93ae-67fd9382c6f4
DOI: 10.21203/rs.3.rs-2057583/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of overviews on adverse events of pharmacological interventionsDOI 10.21203/rs.3.rs-2057583/v1Read

Project Rebuild the Evidence Base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients.Semantic proximity Read

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsSemantic proximity Read

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsSemantic proximity Read

Characteristics of registered systematic reviews on traditional Chinese medicine for COVID-19Semantic proximity Read

Safety assessment of S-1: Real-world adverse event analysis from the FAERS databaseSemantic proximity Read

Annotations to Structure a Systematic Review: Methodological Update and Key Principles Using the S0–S3 FlowSemantic proximity Read

Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity Read

Treatment recommendations based on Network Meta-Analysis: rules for risk-averse decision-makersSemantic proximity Read

Application of observational research methods to real-world studies for rare disease drugs: a scoping review protocolSemantic proximity Read

Randomized trials of ‘personalized’, ‘individualized’ and ‘precision’ interventions are very diverse and have low transparency and high biasSemantic proximity Read

Risk of Bias in Clinical Psychology Meta-Analyses (2000-2020): An OverviewSemantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read